On this page
Quick Reference
Overview and Recommendations
Background
- •Necrotizing fasciitis (NF) is a rapidly progressive, life-threatening infection of the deep soft tissues that spreads along fascial planes, causing necrosis of subcutaneous fat, fascia, and muscle, with relative sparing of overlying skin until late stages. Despite modern critical care, mortality remains 20-30% across contemporary series, with an age-adjusted mortality rate that has risen from 0.44 to 0.71 per 100,000 U.S. population over the past two decades. The critical paradigm shift in management is the recognition that early surgical debridement within 6 hours of presentation reduces mortality by nearly 60% compared to delays beyond 12 hours (NNT 9).
- •The disease is classified into four types based on microbiology and anatomic location: Type I (polymicrobial, most common, often in trunk/perineum), Type II (monomicrobial group A Streptococcus, rapid progression, may present with toxic shock syndrome), Type III (gram-negative, e.g., Vibrio vulnificus, associated with marine exposure), and Type IV (fungal, rare, in immunocompromised). The classification guides empiric antibiotic selection.
- •The pathophysiology involves a cascade: bacterial inoculation into the deep dermis, rapid proliferation within the avascular fascial plane, release of superantigens and cytotoxins, hyperinflammation, microvascular thrombosis, and tissue hypoperfusion creating an antibiotic-impenetrable nidus. This explains why antibiotics alone are insufficient and why surgical debridement must extend to viable, bleeding fascia.
- •Key risk factors include diabetes (44.5% prevalence), age >60 years (strongest independent mortality predictor, OR ~1.16 per year), immunosuppression, chronic kidney disease, cirrhosis, and peripheral vascular disease. Interhospital transfer doubles mortality (OR 2.04). In endemic regions, Vibrio vulnificus infection after seawater exposure in patients with liver disease is a particularly fulminant variant.
- •The most important diagnostic principle is that early diagnosis is missed in 85-100% of cases in large series, underscoring the need for a high index of suspicion. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score has poor sensitivity (68.2% at ≥6) and should not be used to rule out NF. The SIARI score and modified LRINEC (MLRINEC) show improved performance but require validation. The gold standard for diagnosis remains surgical exploration with triple diagnostics: macroscopic inspection, frozen-section histology, and microbiologic culture.
Evaluation
- •Suspect necrotizing fasciitis in any patient with acute soft tissue infection who presents with pain out of proportion to the visible cutaneous findings, this is the sentinel symptom. Other red flags include failure to improve despite broad-spectrum antibiotics, hemorrhagic bullae, crepitus on palpation, hypotension, and systemic toxicity (tachycardia, tachypnea, altered mental status).
- •Ask about recent trauma (58% of patients), insect bites, surgical wounds, water exposure (especially seawater or freshwater), and underlying conditions such as diabetes, immunosuppression, cirrhosis, or chronic kidney disease. The timeline of symptom progression is critical: NF worsens over hours, not days.
- •Examine for swelling (80.8%), erythema (70.7%), and pain. Assess for hemorrhagic bullae (specificity 95.8%, but sensitivity only 25.2%), purple or ecchymotic skin changes, and crepitus (gas on plain radiography in only 24.8%). Perform a focused neurological exam: loss of light touch sensation indicates neural involvement and mandates immediate operative exploration. Pain on passive range of motion of the adjacent joint is a sign of deep fascial involvement.
- •Order laboratory studies: complete blood count, C-reactive protein, serum creatinine, glucose, sodium, and lactate. Calculate the LRINEC score (C-reactive protein, WBC, hemoglobin, sodium, creatinine, glucose). A score ≥6 has sensitivity 68.2%, specificity 84.8%; a score ≥8 has specificity 94.9% but sensitivity 40.8%. Consider the MLRINEC score (adds lactate and liver disease; cut-off 12 gives sensitivity 91.8%, specificity 88.4%) or the SIARI score (site, immunosuppression, age, renal impairment, inflammatory markers). The Shock Index (heart rate/systolic blood pressure) >0.866 predicts mortality in Fournier's gangrene with AUC 0.952.
- •Obtain imaging: CT with IV contrast is the imaging modality of choice, with pooled sensitivity 88.5% and specificity 93.3% for detecting NF. CT findings include fascial thickening, gas in soft tissues, fluid collections, and lack of enhancement of deep fascia. However, a negative CT does not rule out NF, 11.5% of surgically confirmed cases have a normal CT. Do not delay surgical consultation while awaiting imaging.
- •The gold-standard diagnostic test is surgical exploration with triple diagnostics: macroscopic visual inspection (looking for gray, edematous, non-bleeding fascia with 'dishwater' fluid), frozen-section histology (necrosis, PMN infiltration, microvascular thrombosis, bacteria), and Gram stain/culture. This can be performed in the operating room or at the bedside if the patient is too unstable. A negative exploration (22% in one series) is acceptable morbidity compared to the risk of missed diagnosis.
- •Also consider alternative diagnoses: severe cellulitis (responds to antibiotics within 24-48 hours, no pain out of proportion), gas gangrene (clostridial myonecrosis, muscle necrosis), pyomyositis (focal muscle abscess), and deep vein thrombosis. The key differentiating action is surgical exploration if there is any doubt.
- •In populations with atypical presentations (e.g., peritonitis from GAS, centipede bites, scrotal abscess in elderly men with diabetes), maintain a high index of suspicion even without classic cutaneous signs. Immunocompromised patients may present with minimal local signs but rapid deterioration.
Management
- •Initiate immediate surgical consultation upon suspicion of necrotizing fasciitis. The definitive treatment is urgent surgical debridement. Aim for operating room within 6 hours of presentation; every hour of delay increases mortality. The median time to debridement in contemporary series is 8 hours (IQR 4-23). Surgery within 6 hours is associated with an odds ratio of 0.38 for mortality (NNT 9 to prevent one death). If the patient is too unstable for a radical operation, perform incision and drainage (I&D) as a life-saving temporizing measure, I&D is associated with lower amputation and mortality rates compared to upfront extensive debridement in critically ill patients.
- •Start empiric broad-spectrum antibiotics immediately after blood cultures are obtained, before surgical debridement. For Type I (polymicrobial, most common): Piperacillin-tazobactam 4.5 g IV q6h + clindamycin 600-900 mg IV q8h (to inhibit toxin production) + vancomycin 15-20 mg/kg IV q12h (for MRSA coverage). For Type II (group A Streptococcus): Penicillin G 4 million units IV q4h + clindamycin 600-900 mg IV q8h. For suspected Vibrio vulnificus (coastal exposure, bullous lesions): Doxycycline 100 mg IV q12h + ceftriaxone 2 g IV q24h. For patients with risk factors for multidrug-resistant organisms (recent hospitalization, immunosuppression, prior antibiotics), broaden coverage to a carbapenem (e.g., meropenem 1 g IV q8h) and consider an alternative anti-MRSA agent (daptomycin 6-10 mg/kg IV q24h). Adjust based on local antibiogram and culture results.
- •Admit all patients to the ICU for continuous monitoring and aggressive resuscitation. Target lactate clearance as a marker of resuscitation adequacy. Use balanced crystalloids (e.g., lactated Ringer's) for fluid resuscitation. Initiate vasopressors (norepinephrine first-line) to maintain MAP ≥65 mmHg if fluid resuscitation is insufficient. Correct electrolyte abnormalities and maintain glycemic control (target glucose 140-180 mg/dL).
- •Perform surgical debridement with the goal of removing all necrotic fascia and devitalized tissue until viable, bleeding fascia is encountered. Consider a skin-sparing approach if feasible: excise only frankly necrotic skin and fascia, preserving viable skin bridges, and plan for a second-look procedure within 24-48 hours. For perianal NF, a multiple skip incision technique can reduce need for skin grafting and anal stenosis. After initial debridement, apply negative pressure wound therapy (NPWT), a meta-analysis shows NPWT reduces mortality (OR 0.27, 95% CI 0.09-0.87) compared to conventional dressings. Continue NPWT with scheduled re-explorations every 24-48 hours until the wound is clean.
- •Administer adjunctive therapies on a case-by-case basis. Hyperbaric oxygen therapy (HBOT) is controversial: IDSA recommends against routine use, but Chinese expert consensus supports it as an adjunct. If used, HBOT should only be considered after initial surgical debridement and in centers with hyperbaric facilities; it must never delay surgery. Intravenous immunoglobulin (IVIG) may be considered for streptococcal toxic shock syndrome (e.g., 0.4 g/kg/day for 5 days), but evidence is limited. Hemopurification (CRRT, plasma exchange) may be considered in septic shock with multi-organ failure.
- •Monitor for complications: amputation (6-12% of extremity NF, in-hospital mortality 37%), renal failure requiring RRT (OR 3.9 for mortality), entero-atmospheric fistula (8% of open abdomen patients), and long-term functional impairment (fecal incontinence, sexual dysfunction in Fournier's survivors). Involve physical medicine and rehabilitation early for amputation patients. For wound coverage, consider free tissue transfer or local flaps (e.g., DEPAP flap for perineal defects) after infection control.
- •What NOT to do: Do not delay surgery for imaging or culture results. Do not rely on LRINEC score to rule out NF. Do not use HBOT as a substitute for surgical debridement. Do not assume that a negative CT excludes NF. Do not give corticosteroids without careful consideration. Do not discharge the patient until the wound is clean, infection is controlled, and the patient is hemodynamically stable without vasopressor support.
- •When to refer: Immediately to a surgeon for operative exploration. If the patient has septic shock or multi-organ dysfunction, refer to ICU. If the patient has Fournier's gangrene, involve urology or colorectal surgery. If the patient has cervical NF with descending mediastinitis, involve thoracic surgery for possible sternotomy or thoracotomy. For wound reconstruction, involve plastic surgery.
- •Discharge criteria: Resolution of sepsis, no further debridement required, wound healing with NPWT or closed, ability to tolerate oral intake, and adequate pain control. Arrange outpatient follow-up with wound care, physical therapy, and endocrinology if diabetic. Educate patient on signs of recurrence and seek immediate care if symptoms reappear.
Board Review — High Yield
- •Pain out of proportion, classic sentinel symptom of necrotizing fasciitis; warrants immediate suspicion.
- •LRINEC score, six lab values; pooled sensitivity 68.2% at ≥6; do not use to rule out NF.
- •Hemorrhagic bullae, specificity 95.8% for NF; blood-filled blisters indicate dermal infarction.
- •CT sensitivity 88.5%, but 11.5% of NF cases have negative CT; high clinical suspicion overrides negative imaging.
- •Triple diagnostics, gold standard: macroscopic inspection, frozen section, Gram stain/culture.
- •Surgery within 6 hours, associated with 0.38 odds ratio for mortality; NNT 9 to prevent one death.
- •Clindamycin, added to inhibit bacterial toxin production; essential in GAS and polymicrobial regimens.
- •Shock Index >0.866, bedside predictor of mortality in Fournier's gangrene (AUC 0.952).
- •Fournier's gangrene, perineal variant; treat with same urgency; consider fecal diversion.
- •Age >60 years, strongest independent mortality predictor; each year increases risk by ~6%.
- •Negative pressure wound therapy, reduces mortality (OR 0.27) vs conventional dressings; standard after debridement.
Deep Dive — Evidence Details
Definition, Classification and Surgical Nomenclature
- ▸Early surgical debridement is the single most important factor reducing mortality.
- ▸Classification into four types guides empiric antibiotic selection.
Necrotizing fasciitis (NF) is a rapidly progressive infection of deep soft tissues spreading along fascial planes, causing necrosis of subcutaneous fat, fascia, and muscle [2]D5[8]D5. Synonyms include necrotizing soft tissue infection (NSTI), hemolytic streptococcal gangrene, Fournier's gangrene (perineum). Classification guides empiric antibiotics:
| Type | Microbiology | Key Features |
|---|---|---|
| I | Polymicrobial (aerobes + anaerobes) | Most common; trunk, perineum, extremities; immunocompromised |
| II | Monomicrobial (Group A Streptococcus, often with Staphylococcus aureus) | Rapid progression; healthy individuals; toxic shock syndrome |
| III | Gram-negative (Vibrio vulnificus, Aeromonas) | Marine exposure; rapid necrosis |
| IV | Fungal (Candida, Zygomycetes) | Rare; immunocompromised or trauma |
Mortality remains 20-30% [2]D5. Early diagnosis missed in 85-100% [8]D5. Definitive treatment is surgical debridement of all necrotic fascia. The surgical lesion is necrotic fascia with 'dishwater' fluid and easy separation from muscle [8]D5.
Pearl: The single most important factor in reducing mortality is early and aggressive surgical debridement; a high index of suspicion is the clinician's best diagnostic tool [2]D5[8]D5.
| Type | Microbiology | Key Features |
|---|---|---|
| I | Polymicrobial (aerobes + anaerobes) | Most common; occurs in trunk, perineum, extremities; often in immunocompromised patients |
| II | Monomicrobial (Group A Streptococcus, often with Staphylococcus aureus) | Rapid progression; can occur in healthy individuals; may present with toxic shock syndrome |
| III | Gram-negative (e.g., Vibrio vulnificus, Aeromonas) | Associated with marine exposure or freshwater injury; rapid necrosis |
| IV | Fungal (e.g., Candida, Zygomycetes) | Rare; seen in immunocompromised or trauma patients |
Pathophysiology and the Surgical Lesion
- ▸Fascial necrosis creates an antibiotic-impenetrable nidus requiring surgical excision.
- ▸Delayed surgery >12 hours significantly increases mortality.
The surgical lesion (necrotic fascia) results from a cascade: bacterial inoculation → rapid proliferation in avascular fascial plane → release of superantigens, cytotoxins, proteases → hyperinflammation (neutrophil recruitment, ROS, MMPs) → microvascular thrombosis → tissue hypoperfusion → fascial necrosis [24]D5[25]D5. Group A Streptococcus is prototypical; superantigens cause cytokine storm [24]D5. Tissue hypoperfusion creates an antibiotic-impenetrable nidus, explaining why debridement must extend to viable, bleeding fascia [2]D5[25]D5. Delayed surgery >12 hours increases mortality (25.6% vs 14.6% for <6 hours) [23]B2b.
Pearl: The surgical lesion is not the infection itself but the devitalized tissue that perpetuates it, debridement must extend until viable, bleeding fascia is encountered, as residual necrotic tissue guarantees progression despite antibiotics [2]D5[25]D5.
Epidemiology, Etiology and Risk Factors
- ▸Age >60, diabetes, and elevated creatinine are high-risk signals.
- ▸Interhospital transfer is associated with increased mortality (OR 2.04).
Worldwide incidence 0.30-15 per 100,000 [33]B2b. Mortality 20-30% [26]B2a[28]C4. Median age 50-70 years; age is strongest independent predictor of mortality (OR 1.16 per year) [34]B2a. Men more affected. Risk factors: diabetes (44.5% prevalence), septic shock (34.2%, doubles mortality), serum lactate (OR 1.117 per mmol/L) [17]B2b[18]B2b[34]B2a. Protective: Black race (OR 0.780) [34]B2a; prompt surgery within 24h [15]B2b. Geographic disparities: First Nations in Australia have 88x higher incidence [31]B2b. Microbial etiology: Group A Streptococcus in 41% [21]B2b; polymicrobial in 74.8% [17]B2b; ESKAPE pathogens in 31.8% (52% multidrug-resistant) [30]C4. Vibrio vulnificus important in coastal regions with liver disease [10]C4[15]B2b.
Pearl: The combination of age >60 years, diabetes, and elevated serum creatinine should prompt aggressive surgical planning; Clostridium infection and interhospital transfer are particularly high-risk signals that mandate expedited care.
| Risk Factor | OR / RR | Evidence Level | Source |
|---|---|---|---|
| Septic shock | Prevalence 34.2% | 2b | [17]B2b |
| Serum lactate (per 1 mmol/L) | OR 1.117 (P = 0.0017) | 2b | [18]B2b |
Clinical Presentation and Focused Examination
- ▸Pain out of proportion is the most reliable early symptom.
- ▸Hemorrhagic bullae and hypotension are late but highly specific signs.
Pain out of proportion to visible findings is the sentinel symptom [10]C4. Top early features: swelling (80.8%), pain (79.0%), erythema (70.7%) [10]C4. Fever only in 46% [35]B2a. Hypotension has 97.7% specificity but 21% sensitivity [35]B2a. Hemorrhagic bullae: sensitivity 25.2%, specificity 95.8% [35]B2a. Crepitus on plain radiography in 24.8% [10]C4. Neurological: hypoesthesia/anaesthesia from neural involvement [2]D5. Phenotypic variants:
| Variant | Key Features | Frequency |
|---|---|---|
| Type I (polymicrobial) | Mixed flora, gas in tissues, trunk/perineum | Most common in older adults |
| Type II (GAS) | Rapid progression, toxic shock, may lack gas | Up to 40-50% [21]B2b |
| Fournier's gangrene | Perineal/scrotal, indolent onset, high mortality | Distinct subset; mortality 17.1% [43]B2b |
| Type III (Vibrio) | After seawater/raw seafood, liver disease, fulminant | Endemic coastal Asia [10]C4 |
Red flags: pain out of proportion, failure to improve on antibiotics, hemorrhagic bullae, hypotension, crepitus, systemic toxicity, immunosuppression [10]C4[42]B2b.
Pearl: Pain out of proportion is the most reliable early symptom; when present, obtain a CT scan immediately, CT has a pooled sensitivity of 88.5% and specificity of 93.3% for necrotising fasciitis [35]B2a. Do not delay surgical consultation while awaiting imaging.
| Variant | Key Features | Frequency |
|---|---|---|
| Type I (polymicrobial) | Mixed aerobic/anaerobic flora; often involves gas in tissues; typically in trunk, perineum, or postoperative wounds | Most common in older adults with comorbidities |
| Type II (group A Streptococcus) | Rapid progression, often with toxic shock syndrome; may lack gas on imaging; can affect extremities | Up to 40-50% of cases in some series [21]B2b |
| Fournier’s gangrene | Perineal, scrotal, or perianal involvement; often indolent onset with scrotal swelling; high mortality | Accounts for a distinct subset; mortality 17.1% in one cohort [43]B2b |
| Type III (marine Vibrio) | After seawater exposure or ingestion of raw seafood in patients with liver disease; fulminant course | Endemic in coastal Asia [10]C4 |
Diagnosis and Workup
- ▸Surgical exploration with triple diagnostics is the gold standard.
- ▸LRINEC has poor sensitivity; do not use to rule out NF.
Gold standard: surgical exploration with triple diagnostics (macroscopic inspection, frozen-section histology, Gram stain and culture) [2]D5[36]B2b. Laboratory scores: LRINEC (6 variables) has poor sensitivity (68.2% at ≥6) and should not rule out NF [35]B2a. MLRINEC (adds lactate, liver disease) at ≥12 yields sensitivity 91.8%, specificity 88.4% [37]B2b. SIARI score (site, immunosuppression, age, renal, inflammatory markers) outperforms LRINEC (C-statistic 0.832-0.847) [14]B3b.
| Test / Score | Key Finding | Sensitivity | Specificity | AUC |
|---|---|---|---|---|
| LRINEC ≥6 | Standard cut-off | 68.2% [35]B2a | 84.8% [35]B2a | - |
| LRINEC ≥8 | High-specificity | 40.8% [35]B2a | 94.9% [35]B2a | - |
| MLRINEC ≥12 | Add lactate and liver disease | 91.8% [37]B2b | 88.4% [37]B2b | 0.893 [37]B2b |
| SIARI score | Site, immunosuppression, age, renal, CRP/WCC | - | - | 0.832-0.847 [14]B3b |
Imaging: CT is modality of choice (sensitivity 88.5%, specificity 93.3%) [35]B2a. Plain radiography detects gas in only 24.8% [10]C4. Negative CT does not rule out NF (11.5% false negative) [35]B2a. Diagnostic algorithm: high suspicion → exploration; low/intermediate → labs and CT; if CT positive or high suspicion persists → exploration.
Pearl: A normal CT does not rule out necrotizing fasciitis; when clinical suspicion is high, go directly to surgical exploration, because the window for survival is measured in hours, not days.
| Test / Score | Key Finding | Sensitivity | Specificity | AUC |
|---|---|---|---|---|
| LRINEC ≥6 | Standard cut-off | 68.2% [35]B2a | 84.8% [35]B2a | , |
| LRINEC ≥8 | High-specificity cut-off | 40.8% [35]B2a | 94.9% [35]B2a | , |
| MLRINEC ≥12 | Add lactate and liver disease | 91.8% [37]B2b | 88.4% [37]B2b | 0.893 [37]B2b |
| SIARI score | Site, immunosuppression, age, renal, CRP/WCC | , | , | 0.832-0.847 [14]B3b |
| CT with IV contrast | Fascial gas, thickening, fluid | 88.5% [35]B2a | 93.3% [35]B2a | , |
| Plain radiography | Soft-tissue gas | 48.9% [35]B2a | 94.0% [35]B2a | , |
Severity, Surgical Scoring and Risk Stratification
- ▸Shock Index >0.866 is a simple, powerful mortality predictor in Fournier's gangrene.
- ▸LRINEC is primarily diagnostic, not prognostic.
LRINEC score (≥6 moderate, ≥8 high risk) has modest discriminative performance (C-statistic 0.679) [14]B3b. Modified LRINEC (m-LRINEC) at ≥17 achieves sensitivity 93.2%, specificity 86.9% (AUC 0.935) [58]B3b. For Fournier's gangrene: FGSI (temperature, HR, RR, Na, K, Cr, HCO3, Hct, WBC) has AUC 0.818 for mortality [45]B2b; qSOFA has higher specificity (94.6%) but lower sensitivity (62.2%) [45]B2b; Shock Index (HR/SBP) outperforms all (AUC 0.952, threshold >0.866) [43]B2b. SIARI score superior to LRINEC for diagnosis [14]B3b. Mortality in Necrotizing Fasciitis (MNF) score (female, age>60, WBC ≤5 or ≥35, Cr≥1.6, pulse>130) has AuROC 76.18% [57]B3b. MELD score independently predicts 30-day mortality (HR 1.61 per point) [59]B3b. Interhospital transfer increases mortality (OR 2.04) [32]B2b.
Pearl: The Shock Index (heart rate/systolic blood pressure) is a simple, bedside-available tool that outperforms complex scoring systems for mortality prediction in Fournier's gangrene; a threshold >0.866 should prompt immediate escalation of care [43]B2b.
| Score | Components | Primary Use | Performance (AUC) | Key Threshold |
|---|---|---|---|---|
| LRINEC | CRP, WBC, Hb, Na, Cr, glucose | Diagnostic adjunct | 0.679 [14]B3b | ≥6 |
| m-LRINEC | Adds diabetes, kidney disease; uses hs-CRP | Diagnostic | 0.935 [58]B3b | ≥17 |
| SIARI | Site, immunosuppression, age, Cr, CRP, WBC | Diagnostic | 0.847 [14]B3b | Not specified |
| FGSI | Temp, HR, RR, Na, K, Cr, HCO3, Hct, WBC | Prognostic (mortality) | 0.818 [45]B2b | Not specified |
| qSOFA | RR, SBP, GCS | Prognostic (mortality) | 0.818 [45]B2b | ≥2 |
| Shock Index | HR/SBP | Prognostic (mortality) | 0.952 [43]B2b | >0.866 |
| MNF | Gender, age, WBC, Cr, pulse | Prognostic (mortality) | 0.762 [57]B3b | Low ≤2.5, high ≥7 |
| MELD | Bilirubin, Cr, INR | Prognostic (30-day mortality) | Not reported as AUC | Per point HR 1.61 [59]B3b |
Acute Management and Resuscitation
- ▸Empiric antibiotics must cover likely pathogens based on type and local resistance.
- ▸Surgical debridement should not be delayed for resuscitation or imaging.
All patients require immediate ICU admission (83% in one cohort) [21]B2b. Resuscitation guided by serum lactate (AUC 0.719) [17]B2b; target lactate clearance. Balanced crystalloids preferred. Vasopressors (norepinephrine first-line) for MAP ≥65 mmHg. Empiric antibiotics started immediately after blood cultures:
| Regimen | Indication | Key considerations |
|---|---|---|
| Piperacillin-tazobactam + clindamycin + vancomycin | Polymicrobial (Type I) | Covers gram-negative, anaerobes, MRSA; clindamycin inhibits toxin production [20]C4[30]C4 |
| Penicillin G (high-dose) + clindamycin | Type II (GAS) | Clindamycin inhibits toxin synthesis [46]C4 |
| Doxycycline + ceftriaxone | Suspected Vibrio vulnificus | Reduces mortality with early surgery [15]B2b |
| Amphotericin B or echinocandin | Suspected fungal NF | Fungal NF has threefold higher mortality [47]C4 |
For MDRO risk: carbapenem + anti-MRSA [30]C4. Adjunctive therapies: hyperbaric oxygen (HBOT) not routinely recommended by IDSA; may be considered after debridement [26]B2a. IVIG for streptococcal toxic shock syndrome (limited evidence). Surgical debridement is definitive; median time to debridement 8 hours (IQR 4-23) [21]B2b.
Pearl: The most critical intervention for necrotizing fasciitis is early surgical debridement; resuscitation and empiric antibiotics are temporizing measures that must not delay the operative procedure.
| Regimen | Indication | Key considerations |
|---|---|---|
| + + | Polymicrobial (Type I) | Covers gram-negative, anaerobes, MRSA; clindamycin inhibits toxin production [20]C4[30]C4 |
| (high-dose) + | Type II (Group A Streptococcus) | Clindamycin inhibits toxin synthesis; penicillin alone may be ineffective in high inoculum [46]C4 |
| + | Suspected | Reduces mortality when combined with early surgery [15]B2b |
| Empiric antifungal ( or ) | Suspected fungal NF | Fungal NF has threefold higher mortality; early cultures are critical [47]C4 |
Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice
- ▸Surgery within 6 hours significantly reduces mortality and amputation.
- ▸Incision and drainage can be a life-saving temporizing measure in unstable patients.
Surgical exploration is indicated whenever NF is suspected. Delay increases mortality: surgery within 0-6 hours mortality 14.6%, 6-12 hours 16.1%, >12 hours 25.6% [23]B2b. Surgery within 6 hours reduces odds of death or amputation (aOR 0.19) [23]B2b. Interhospital transfer adds delay and increases mortality (OR 2.04) [32]B2b. Nonoperative management is universally fatal; no randomized trial exists. Incision and drainage (I&D) as initial temporizing measure may reduce amputation (aOR 0.107) and mortality (aOR 0.172) compared with upfront extensive debridement in critically ill patients [70]B3b. Factors increasing urgency: hemodynamic instability (OR 19.58 for mortality) [63]B3b, cervical NF with descending mediastinitis, Vibrio or GAS infection, ASA ≥3 (OR 9.26) [1]B2b.
Pearl: Any delay beyond 12 hours from presentation to initial debridement doubles the odds of death or amputation; aim for incision within 6 hours, and if the patient is too unstable for a radical operation, perform immediate incision and drainage as a life-saving temporizing measure.
| Time from presentation to surgery | Mortality rate | Adjusted odds ratio for death/amputation (95% CI) | NNT to prevent one death vs. >12 h |
|---|---|---|---|
| 0-6 hours | 14.6% | 0.19 (0.05-0.62) | 9 |
| 6-12 hours | 16.1% | 0.23 (0.05-0.90) | 11 |
| >12 hours | 25.6% | (reference) | - |
Data from a single-center Japanese cohort (n = 187) [23]B2b. Mortality rates are crude; adjusted odds ratios are for the composite of death or amputation.
Operative Approach, Technique Selection and Perioperative Optimization
- ▸Staged debridement with initial I&D may be superior in critically ill patients.
- ▸NPWT reduces mortality and should be standard after debridement.
Initial incision and drainage (I&D) followed by staged debridement may be superior to single-stage wide en bloc debridement in critically ill patients (lower amputation and mortality) [70]B3b. Skin-sparing debridement (SSd) preserves viable skin; 75% achieve delayed primary closure without increased mortality [74]B2a. Multiple skip incision technique for perianal NF reduces need for grafting [61]B3b. Negative pressure wound therapy (NPWT) reduces mortality (OR 0.27) [73]A1a and shortens hospital stay [55]B3b. Amputation reserved for non-salvageable limbs; late amputation (>3 days) associated with higher mortality [11]B2b. Bedside guillotine amputation may be life-saving in crashing patients [77]C4. Perioperative optimization: aggressive fluid resuscitation, broad-spectrum antibiotics, glycemic control (target 140-180 mg/dL). Open abdomen with NPWT and mesh-mediated traction achieves 84% primary fascial closure [69]B3b.
Pearl: In critically ill NF patients, initial incision and drainage with source control, followed by staged debridement and negative pressure wound therapy, is associated with lower mortality and amputation rates than single-stage extensive debridement, especially when the patient is too unstable for a prolonged procedure [70]B3b.
| Technique | Key Features | Reported Outcomes | Evidence Level |
|---|---|---|---|
| En bloc debridement | Wide excision of skin, subcutaneous tissue, and fascia en bloc | Traditional approach; may leave large defects requiring skin grafting | Retrospective series [70]B3b |
| Skin-sparing debridement | Excision of only necrotic tissue; preserve viable skin | 75% total delayed primary closure; no increased mortality or LOS | Systematic review (poor quality) [74]B2a |
| Multiple skip incision | Several small incisions along fascial planes | Reduced need for grafting; less perianal stenosis | Retrospective study (PNF) [61]B3b |
| Outcome | NPWT (VAC) | Conventional | Effect Size (95% CI) | Reference |
|---|---|---|---|---|
| Mortality | Lower | Higher | OR 0.27 (0.09-0.87) | [73]A1a |
| Time to leukocyte normalization | Shorter | Longer | -1.8 days (-3.5 to -0.1) | [55]B3b |
| Antibiotic duration | Shorter | Longer | -2.0 days (-3.7 to -0.4) | [55]B3b |
| Hospital stay | Shorter | Longer | -3.0 days (-5.7 to -0.4) | [55]B3b |
| Operation frequency (odontogenic CNF) | Lower | Higher | Significant reduction | [66]A1b |
Complications and Their Management
- ▸Amputation is a marker of advanced disease with high mortality.
- ▸Multidisciplinary management is essential for complications.
Amputation occurs in 6-12% of extremity NF [11]B2b[21]B2b; in-hospital mortality 37% [11]B2b. Late amputation (>3 days) associated with worse outcomes [11]B2b. Hip disarticulation/hemipelvectomy: early mortality 26%, 63% survivors wheelchair-dependent [67]C4. In-hospital mortality 9-21% [13]C4[21]B2b[31]B2b[82]B2b. Renal failure requiring RRT (OR 3.9 for mortality) and abdominal compartment syndrome (OR 3.1) are predictors in open abdomen [69]B3b. Entero-atmospheric fistula (8% of open abdomen) not associated with increased mortality [69]B3b. Long-term QoL impairment common in Fournier's gangrene survivors (fecal incontinence, sexual dysfunction) [81]B2a. ESKAPE pathogens in 32% of community-acquired NF; 52% multidrug-resistant [30]C4. Fungal NF mortality 67% [47]C4. Management: multidisciplinary, serial debridement, staged reconstruction, antibiotic stewardship.
| Complication | Incidence | Key Risk Factors | Management |
|---|---|---|---|
| Amputation | 6-12% [11]B2b[21]B2b | Debridement delay >3 d, diabetes, skin necrosis | Primary or staged amputation; rehabilitation |
| In-hospital mortality | 9-21% [13]C4[21]B2b[31]B2b[82]B2b | Age >60, renal failure, hypotension, fungal infection | ICU support, source control |
| Renal failure requiring RRT | OR 3.9 for mortality in OAT [69]B3b | Abdominal compartment syndrome | RRT, avoid nephrotoxins |
| Entero-atmospheric fistula | 8% of OAT patients [69]B3b | Prolonged open abdomen | NPWT, staged closure, nutrition |
| Long-term QoL impairment (FG) | 5-21% long-term mortality; functional deficits common [81]B2a | Extent of initial debridement | Multidisciplinary rehabilitation, psych support |
Pearl: Amputation is a marker of advanced disease; the majority of patients requiring amputation die, and survivors face profound functional impairment, making early recognition and aggressive initial debridement the most effective complication-prevention strategy.
| Complication | Incidence | Key Risk Factors | Management |
|---|---|---|---|
| Amputation (extremity NF) | 6-12% [11]B2b[21]B2b | Debridement delay >3 d, diabetes, skin necrosis | Primary or staged amputation; rehabilitation |
| In-hospital mortality | 9-21% [13]C4[21]B2b[31]B2b[82]B2b | Age >60, renal failure, hypotension, fungal infection | ICU support, source control |
| Renal failure requiring RRT | OR 3.9 for mortality in OAT [69]B3b | Abdominal compartment syndrome | RRT, avoid nephrotoxins |
| Entero-atmospheric fistula | 8% of OAT patients [69]B3b | Prolonged open abdomen | NPWT, staged closure, nutrition |
| Long-term QoL impairment (FG) | 5-21% long-term mortality; functional deficits common [81]B2a | Extent of initial debridement | Multidisciplinary rehabilitation, psych support |
History and Evolution of Treatment
- ▸Frozen-section biopsy revolutionized early diagnosis and reduced mortality.
- ▸HBOT is not a substitute for surgical debridement.
Term 'necrotizing fasciitis' introduced by Wilson in 1952 [86]B2b. Stamenkovic and Lew (1984) showed frozen-section biopsy within 21 hours reduced mortality from 73% [88]C4. LRINEC score introduced by Wong et al. provided standardized diagnostic tool but has variable sensitivity [86]B2b[90]D5. Empiric antibiotics evolved from penicillin to broad-spectrum combinations including clindamycin for toxin inhibition. IVIG used for streptococcal toxic shock syndrome (limited evidence). Hyperbaric oxygen therapy (HBOT) was proposed as alternative but no mortality benefit; IDSA recommends against routine use [26]B2a. Modern care is multidisciplinary with protocol-driven resuscitation, antibiotics, and urgent surgical exploration. Next-generation sequencing and NPWT are recent advances [92]C4. Central lesson: window for intervention is hours, not days.
Pearl: Hyperbaric oxygen therapy has been abandoned as a replacement for surgery; it is not supported by mortality benefit evidence.
| Year | Milestone | Impact |
|---|---|---|
| 5th century BC | Hippocrates first describes the condition [86]B2b | Earliest recorded recognition |
| 1952 | Wilson introduces the term "necrotizing fasciitis" [86]B2b | Standardized nomenclature |
| 1991 | Patiño et al. report 47.7% mortality in volcanic cataclysm cohort [87]C4 | Highlighted need for prompt radical debridement in disasters |
| 2004 | Wong et al. introduce the LRINEC score [86]B2b | Provided a standardized diagnostic tool with 92% PPV |
| 2000s | Clindamycin incorporated into empiric regimens for toxin suppression | Reduced toxin-mediated shock |
| 2010s | IVIG used for streptococcal toxic shock syndrome (limited evidence) | Adjunctive immunotherapy |
| 2020s | NGS-based rapid pathogen identification emerges [93]C4 | Faster targeted therapy; hyperbaric oxygen abandoned as sole therapy |
Prognosis and Natural History
- ▸Age >60, septic shock, and elevated lactate are strong mortality predictors.
- ▸Number of debridements is associated with better survival.
In-hospital mortality 16-30% [26]B2a[29]B2b[63]B3b[86]B2b[96]B2b[98]B2b. US age-adjusted mortality rose from 0.44 to 0.71 per 100,000 (2003-2020) [99]B2c. Upper-extremity NF: 11% mortality, 14% amputation [1]B2b. Fournier's gangrene: 9.6-15% mortality [18]B2b[27]C4. Untreated disease progresses rapidly to septic shock and MODS; 83% of Vibrio deaths within 72 hours [15]B2b. Factors associated with mortality:
| Predictor | Strength | Representative Data |
|---|---|---|
| Age >60 years | Strong | OR 3.80 [98]B2b |
| Septic shock | Doubles risk | 34.2% vs 17.8% mortality [17]B2b |
| Serum lactate | Strong prognostic | AUC 0.719 [17]B2b; OR 1.117 per mmol/L [18]B2b |
| Hemorrhagic bullae | Surrogate for severe disease | OR 4.7 in late amputation [11]B2b |
| Culture-negative infection | Strong | OR 6.07 [17]B2b |
| ESKAPE pathogens | Higher mortality with MDR | 52% multidrug-resistant [30]C4 |
Long-term morbidity: amputation, open abdomen (median ICU stay 15 days, hospital 29 days) [69]B3b, perianal NF often requires fecal diversion [101]B2b. Number of debridements associated with better survival (OR 0.83 per debridement) [63]B3b.
Pearl: Age is the single most consistent predictor of mortality, with each year increasing risk by approximately 6% [29]B2b; a patient over 70 with septic shock and lactate >4 mmol/L carries a mortality risk exceeding 50%, this should trigger immediate escalation of care and frank discussion with the family.
| Study | Population | In-Hospital Mortality |
|---|---|---|
| [29]B2b (Italy, multicentre) | 379 NSTI patients | 16.7% |
| [96]B2b (Qatar, single centre) | 331 NF patients | 26% |
| [63]B3b (Germany, single centre) | 192 NF/Fournier's patients | 27.6% |
| [86]B2b (Netherlands, multicentre) | 58 ICU patients | 29.3% |
| [98]B2b (Switzerland, single centre) | 75 NF patients | 27% |
| [17]B2b (Colombia, single centre) | 111 NF patients | 23.4% |
| [27]C4 (Switzerland, Fournier's) | 20 Fournier's patients | 15% |
| [18]B2b (China, Fournier's) | 228 Fournier's patients | 9.6% |
| [1]B2b (USA, upper extremity) | 122 upper-extremity NSTI | 11% (30-day) |
| [32]B2b (USA, Nationwide Inpatient Sample) | 9,958 NF patients | ED: 8.7%, IT: 15.5% |
| [99]B2c (USA, CDC WONDER) | 19,158 NF deaths (2003-2020) | AAMR 0.44→0.71/100,000 |
Special Populations
- ▸Elderly patients with age >60 and elevated creatinine need aggressive management.
- ▸Immunocompromised patients require broader empiric antibiotics and low threshold for surgery.
Pediatrics: NF occurs at any age; presentation may mimic cellulitis. LRINEC/SIARI not validated. Imaging: ultrasound/MRI preferred to CT. Treatment: surgical debridement, weight-based antibiotics (piperacillin-tazobactam, clindamycin). Prognosis may be better than adults. Pregnancy: No specific evidence. MRI preferred over CT; if CT needed, use fetal shielding. Antibiotics safe in pregnancy (penicillins, clindamycin, metronidazole). Debridement should not be delayed. Consider cesarean if near term and infection not involving perineum. Elderly: Age >60 is strongest mortality predictor (OR 3.80) [98]B2b. Each year increases odds of death by 6-7% [17]B2b[29]B2b. Higher ASA (≥3) increases risk (OR 9.26) [1]B2b. Interhospital transfer increases mortality (OR 2.04) [32]B2b. Immunocompromised: Diabetes, malignancy, alcohol dependence increase risk. Prone to polymicrobial and resistant infections. Broader empiric coverage needed (carbapenem + clindamycin). Culture-negative infections have higher mortality (OR 6.07) [17]B2b. Low threshold for surgical exploration.
Pearl: In elderly patients, age >60 years and serum creatinine >2 mg/dL should trigger immediate aggressive resuscitation and early surgical consultation; in immunocompromised patients, a low threshold for surgical exploration is warranted even when signs are subtle.
Prevention, Screening & Surveillance
- ▸Prevention focuses on modifiable risk factors: diabetes, immunosuppression, alcoholism.
- ▸Patient education on warning signs is crucial for early presentation.
Primary prevention: Tight glycemic control, weight management, avoidance of alcohol abuse. In scabies-endemic areas, scabies control reduces impetigo and severe SSTIs [103]B2b. Proper perioperative antibiotic prophylaxis and sterile technique. Secondary prevention: Recurrence rare but documented; median interval 25.5 days for iGAS [107]C4. Immunologic evaluation after first iGAS infection. For Actinomyces europaeus NF, 3-month course of oral amoxicillin-clavulanate may prevent relapse [20]C4. Post-discharge follow-up at 2-4 weeks. Screening: No formal screening; counsel high-risk individuals (diabetes, malignancy, immunosuppression, alcohol use disorder) to seek immediate care for rapidly worsening skin lesions. Vaccines: Tetanus immunization essential for open wounds. Routine influenza and pneumococcal vaccines for diabetes/immunosuppressed. Patient education: Teach cardinal warning signs: pain out of proportion, rapidly spreading erythema, swelling, fever, systemic toxicity. Emphasize wound care and avoidance of water exposure in open wounds.
Pearl: The same triad, diabetes, immunosuppression, and alcoholism, that predicts mortality also identifies the patients most likely to benefit from intensive prevention counseling and early surveillance [61]B3b.
References
- [1]
Nawijn F, Verhiel SHWL, Lunn KN et al.. “Factors Associated with Mortality and Amputation Caused by Necrotizing Soft Tissue Infections of the Upper Extremity: A Retrospective Cohort Study.” World journal of surgery (2020). PMID: 31664494 ↗
L2COHORTCited in: Definition, Classification and Surgical Nomenclature, Epidemiology, Etiology and Risk Factors, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prognosis and Natural History, Special Populations & Pregnancy - [2]
Hietbrink F, Bode LG, Riddez L et al.. “Triple diagnostics for early detection of ambivalent necrotizing fasciitis.” World journal of emergency surgery : WJES (2016). PMID: 27766113 ↗
L5OTHERCited in: Definition, Classification and Surgical Nomenclature, Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Complications and Their Management, Prognosis and Natural History - [3]
Gilardi R, Galassi L, Del Bene M et al.. “Infective complications of cosmetic tourism: A systematic literature review.” Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2023). PMID: 37320953 ↗
L4SR_OBSCited in: Definition, Classification and Surgical Nomenclature - [4]
Kim DH, Kim SW, Hwang SH. “Application of the laboratory risk indicator for necrotizing fasciitis score to the head and neck: a systematic review and meta-analysis.” ANZ journal of surgery (2022). PMID: 35014152 ↗
L2SR_OBSCited in: Definition, Classification and Surgical Nomenclature - [5]
Tarricone A, Mata K, Gee A et al.. “A Systematic Review and Meta-Analysis of the Effectiveness of LRINEC Score for Predicting Upper and Lower Extremity Necrotizing Fasciitis.” The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons (2021). PMID: 34657810 ↗
L2SR_OBSCited in: Definition, Classification and Surgical Nomenclature - [6]
Kusumoto J, Iwata E, Huang W et al.. “Hematologic and inflammatory parameters for determining severity of odontogenic infections at admission: a retrospective study.” BMC infectious diseases (2022). PMID: 36503406 ↗
L3COHORTCited in: Definition, Classification and Surgical Nomenclature - [7]
Oud L, Watkins P. “Necrotizing Fasciitis Associated with Pregnancy: a Population-Based Cohort Study.” Infectious diseases and therapy (2014). PMID: 25069416 ↗
L2COHORTCited in: Definition, Classification and Surgical Nomenclature - [8]
Lancerotto L, Tocco I, Salmaso R et al.. “Necrotizing fasciitis: classification, diagnosis, and management.” The journal of trauma and acute care surgery (2012). PMID: 22491537 ↗
L5REVIEW_NARRATIVECited in: Definition, Classification and Surgical Nomenclature - [9]
Erickson BA, Flynn KJ. “Management of Necrotizing Soft Tissue Infections (Fournier's Gangrene) and Surgical Reconstruction of Debridement Wound Defects.” The Urologic clinics of North America (2022). PMID: 35931437 ↗
L5REVIEW_NARRATIVECited in: Definition, Classification and Surgical Nomenclature - [10]
Goh T, Goh LG, Ang CH et al.. “Early diagnosis of necrotizing fasciitis.” The British journal of surgery (2013). PMID: 24338771 ↗
L4SR_OBSCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Complications and Their Management, Prognosis and Natural History - [11]
Chang CP, Hsiao CT, Lin CN et al.. “Risk factors for mortality in the late amputation of necrotizing fasciitis: a retrospective study.” World journal of emergency surgery : WJES (2018). PMID: 30302124 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Complications and Their Management, Prognosis and Natural History, Special Populations & Pregnancy - [12]
Karkas A, Chahine K, Schmerber S et al.. “Optimal treatment of cervical necrotizing fasciitis associated with descending necrotizing mediastinitis.” The British journal of surgery (2010). PMID: 20169565 ↗
L4OTHERCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Diagnosis and Workup, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Complications and Their Management, Prognosis and Natural History, Special Populations & Pregnancy, Prevention, Screening & Surveillance - [13]
Lunar J, Ranketi SS, Owino B et al.. “Necrotizing Fasciitis: A Predictable Burden in Rural Kenya.” World journal of surgery (2020). PMID: 32435826 ↗
L4OTHERCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Complications and Their Management, History and Evolution of Treatment, Prognosis and Natural History, Special Populations & Pregnancy - [14]
Cribb BI, Wang MTM, Kulasegaran S et al.. “The SIARI Score: A Novel Decision Support Tool Outperforms LRINEC Score in Necrotizing Fasciitis.” World journal of surgery (2019). PMID: 31214830 ↗
L3OTHERCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Severity, Surgical Scoring and Risk Stratification, Special Populations & Pregnancy - [15]
Kuo Chou TN, Chao WN, Yang C et al.. “Predictors of mortality in skin and soft-tissue infections caused by Vibrio vulnificus.” World journal of surgery (2010). PMID: 20151130 ↗
L2OTHERCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prognosis and Natural History, Special Populations & Pregnancy - [16]
Gumma MEF, Wallace BK, Cohen AJ. “Association between SGLT2 inhibitor use and Fournier's gangrene after genital or perineal surgery: a retrospective cohort study.” World journal of urology (2026). PMID: 42258009 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Complications and Their Management, Special Populations & Pregnancy - [17]
Barrientos ML, Cordoba ASR, Valencia MDML et al.. “Risk factors and predictors of in-hospital mortality in necrotizing fasciitis: a five-year retrospective cohort study from a tertiary care center in Colombia.” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2026). PMID: 42113249 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Acute Management and Resuscitation, Prognosis and Natural History, Special Populations & Pregnancy - [18]
Mou C, Xu W, Fang Y et al.. “Risk factors, microbiological resistance, and prognostic scoring in Fournier's gangrene: a retrospective cohort study.” BMC infectious diseases (2026). PMID: 41981496 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Acute Management and Resuscitation, Prognosis and Natural History, Special Populations & Pregnancy - [19]
Jiang Y, Huang D, Wu H. “Scrotal abscess and Fournier gangrene caused by Klebsiella pneumoniae: a case series and literature review.” BMC infectious diseases (2026). PMID: 41742047 ↗
L4CASE_REPORTCited in: Pathophysiology and the Surgical Lesion, Clinical Presentation and Focused Examination, Diagnosis and Workup, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, History and Evolution of Treatment - [20]
Qi R, Dong J, Pan H et al.. “Necrotizing fasciitis caused by Actinomyces europaeus: a case report and literature review.” BMC infectious diseases (2026). PMID: 41654754 ↗
L4CASE_REPORTCited in: Pathophysiology and the Surgical Lesion, Diagnosis and Workup, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prevention, Screening & Surveillance - [21]
de Haan J, Neeter LMFH, Suijker J et al.. “Characteristics, treatments, and outcomes of patients with necrotizing soft tissue infections: a Dutch multicenter cohort study.” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2025). PMID: 41148308 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Complications and Their Management, Special Populations & Pregnancy - [22]
Meloni M, Uccioli L, Andreadi A et al.. “Incidence and causes of major amputation in patients with diabetic foot ulcers: data from a retrospective study.” Acta diabetologica (2025). PMID: 40906200 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Epidemiology, Etiology and Risk Factors, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Special Populations & Pregnancy - [23]
Fujishima C, Matsuoka Y, Kinoshita H et al.. “Epidemiology and Early Surgical Intervention in Necrotizing Fasciitis: A Retrospective Cohort Study in Japan.” The Journal of dermatology (2025). PMID: 40452628 ↗
L2COHORTCited in: Pathophysiology and the Surgical Lesion, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice - [24]
Yang S, Jin L, Liu L et al.. “Host-response trajectories in necrotizing fasciitis: host-pathogen interactions, immune evasion, and immunoparalysis.” Frontiers in cellular and infection microbiology (2026). PMID: 42459336 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and the Surgical Lesion - [25]
Larson NJ, Rogers FB, Dries DJ et al.. “Necrotizing Soft Tissue Infections: A Surgical Perspective.” Journal of intensive care medicine (2025). PMID: 41204123 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology and the Surgical Lesion - [26]
Huang C, Zhong Y, Yue C et al.. “The effect of hyperbaric oxygen therapy on the clinical outcomes of necrotizing soft tissue infections: a systematic review and meta-analysis.” World journal of emergency surgery : WJES (2023). PMID: 36966323 ↗
L2SR_OBSCited in: Epidemiology, Etiology and Risk Factors, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prognosis and Natural History - [27]
Wetterauer C, Ebbing J, Halla A et al.. “A contemporary case series of Fournier's gangrene at a Swiss tertiary care center-can scoring systems accurately predict mortality and morbidity?” World journal of emergency surgery : WJES (2018). PMID: 29977327 ↗
L4CASE_REPORTCited in: Epidemiology, Etiology and Risk Factors, Severity, Surgical Scoring and Risk Stratification, Complications and Their Management, Prognosis and Natural History, Special Populations & Pregnancy - [28]
Benjelloun el B, Souiki T, Yakla N et al.. “Fournier's gangrene: our experience with 50 patients and analysis of factors affecting mortality.” World journal of emergency surgery : WJES (2013). PMID: 23547796 ↗
L4OTHERCited in: Epidemiology, Etiology and Risk Factors - [29]
Podda M, Ceresoli M, Virdis F et al.. “Factors associated with in-hospital mortality in necrotising soft tissue infections. a multicentre retrospective cohort study.” European journal of trauma and emergency surgery : official publication of the European Trauma Society (2026). PMID: 42283768 ↗
L2COHORTCited in: Epidemiology, Etiology and Risk Factors, Prognosis and Natural History, Special Populations & Pregnancy - [30]
Radu-Adameşteanu MO, Dragu ER, Chioaru BL et al.. “Antimicrobial Resistance of ESKAPE Pathogens Identified in Patients with Necrotizing Fasciitis: A 10-Year Retrospective Study.” Medicina (Kaunas, Lithuania) (2026). PMID: 42075537 ↗
L4COHORTCited in: Epidemiology, Etiology and Risk Factors, Acute Management and Resuscitation, Complications and Their Management, Prognosis and Natural History - [31]
Whitehouse S, Cheong JY, Chiam HC. “Retrospective Cohort Study Comparing Outcomes and High-Risk Factors of Patients Presenting with Necrotizing Soft Tissue Infections in Far North Queensland-20 Years of Experience.” Tropical medicine and infectious disease (2025). PMID: 41150376 ↗
L2COHORTCited in: Epidemiology, Etiology and Risk Factors, Complications and Their Management - [32]
Holena DN, Mills AM, Carr BG et al.. “Transfer status: a risk factor for mortality in patients with necrotizing fasciitis.” Surgery (2011). PMID: 21783216 ↗
L2OTHERCited in: Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Diagnosis and Workup, Severity, Surgical Scoring and Risk Stratification, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Prognosis and Natural History, Special Populations & Pregnancy - [33]
Walwekar R, Ramalingam V, Walwekar A. “A prospective study to assess the prognosis of patients with necrotizing fasciitis using laboratory risk indicator for necrotizing fasciitis (LRINEC) scoring system in a tertiary care hospital.” Journal of basic and clinical physiology and pharmacology (2025). PMID: 41397428 ↗
L2COHORTCited in: Epidemiology, Etiology and Risk Factors, Clinical Presentation and Focused Examination, Severity, Surgical Scoring and Risk Stratification - [34]
Huang W, Wei J, Wu Y et al.. “Mortality risk factors among patients with necrotizing fasciitis: a systematic review and meta-analysis of cohort studies.” Postgraduate medicine (2025). PMID: 41404821 ↗
L2SR_OBSCited in: Epidemiology, Etiology and Risk Factors - [35]
Fernando SM, Tran A, Cheng W et al.. “Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis.” Annals of surgery (2019). PMID: 29672405 ↗
L2SR_OBSCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup, Prognosis and Natural History - [36]
Nawijn F, Houwert RM, van Wessem KPJ et al.. “A 5-Year Evaluation of the Implementation of Triple Diagnostics for Early Detection of Severe Necrotizing Soft Tissue Disease: A Single-Center Cohort Study.” World journal of surgery (2019). PMID: 30953197 ↗
L2COHORTCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prognosis and Natural History - [37]
Wu PH, Wu KH, Hsiao CT et al.. “Utility of modified Laboratory Risk Indicator for Necrotizing Fasciitis (MLRINEC) score in distinguishing necrotizing from non-necrotizing soft tissue infections.” World journal of emergency surgery : WJES (2021). PMID: 34039397 ↗
L2OTHERCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup - [38]
Monneuse O, Tissot E, Gruner L et al.. “Diagnosis and treatment of spontaneous group A streptococcal peritonitis.” The British journal of surgery (2010). PMID: 20013929 ↗
L4OTHERCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup, Acute Management and Resuscitation, History and Evolution of Treatment - [39]
Cathala L, Dumontier C, Bastard C et al.. “A retrospective study of centipede bites in Guadeloupe, West Indies: epidemiology, medical and surgical management.” Clinical toxicology (Philadelphia, Pa.) (2026). PMID: 41524529 ↗
L4COHORTCited in: Clinical Presentation and Focused Examination, Acute Management and Resuscitation, Special Populations & Pregnancy - [40]
Xu Z, Zhang R, Han Q et al.. “Explainable Machine Learning Models Using Routine Clinical Data for Early Prediction of Necrotizing Fasciitis: A Single-Center Retrospective Study.” ANZ journal of surgery (2025). PMID: 41277728 ↗
L2COHORTCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup - [41]
Kayar R, Kayar K, Artuk İ et al.. “Diagnostic Accuracy of Red Cell Distribution Width-Derived Indices for Predicting In-Hospital Mortality in Scrotal Fournier's Gangrene: A Retrospective Cohort Study.” Surgical infections (2025). PMID: 41264355 ↗
L2COHORTCited in: Clinical Presentation and Focused Examination, Diagnosis and Workup - [42]
Algethamy HM, Alhazmi RN, Alghalayini FK et al.. “Predictors of sepsis, intensive care unit admission, and death in patients hospitalized for complicated skin and soft tissue infections: Retrospective study at a large tertiary-care center.” SAGE open medicine (2025). PMID: 40297785 ↗
L2COHORTCited in: Clinical Presentation and Focused Examination, History and Evolution of Treatment - [43]
Aytin YE, Ataçer MO, Öztürk OA et al.. “Prognostic value of the shock index in Fournier's gangrene: a retrospective cohort study comparing established mortality scoring systems.” Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES (2026). PMID: 42261857 ↗
L2COHORTCited in: Clinical Presentation and Focused Examination, Severity, Surgical Scoring and Risk Stratification - [44]
S R, Srinivas S, B D M. “Clinical Presentation, Risk Factors, and Clinical Outcomes of Patients Who Underwent Major Upper-Limb Amputation for Nontraumatic Indications: A Retrospective Study.” Cureus (2026). PMID: 42037928 ↗
L4COHORTCited in: Clinical Presentation and Focused Examination, Complications and Their Management - [45]
Bestari MG, Adi K, Mustafa A. “Quick sequential organ failure assessment and Fournier gangrene severity index as predictors for mortality in Fournier gangrene patients: A retrospective cohort study of 153 patients.” The American journal of emergency medicine (2025). PMID: 40112683 ↗
L2COHORTCited in: Diagnosis and Workup, Severity, Surgical Scoring and Risk Stratification - [46]
Li X, Xin J, Bao W et al.. “Case report: Necrotizing fasciitis involving the bilateral scrotum and right leg caused by Streptococcus pyogenes in a healthy male: a multidisciplinary diagnostic and therapeutic analysis.” BMC infectious diseases (2026). PMID: 41703483 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, Acute Management and Resuscitation - [47]
Haider A, Virji SN, Dildar M et al.. “Time against tissue: case reports of fungal necrotizing fasciitis and the cost of delayed aggressive interventions.” BMC infectious diseases (2025). PMID: 41382032 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, Acute Management and Resuscitation, Complications and Their Management - [48]
Sfaciotte RAP, Carniel F, Parussolo L et al.. “Fatal necrotizing fasciitis in a dog caused by NDM-producing extensively drug-resistant Acinetobacter baumannii: a case report.” European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2025). PMID: 41123792 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, Acute Management and Resuscitation - [49]
Albedah K, Alotaibi A, Alelaiyan S et al.. “Unexpected necrotizing fasciitis in first day post laparoscopic hernia repair caused by rare species of Aeromonas; case report.” BMC infectious diseases (2025). PMID: 41068638 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, Operative Approach, Technique Selection and Perioperative Optimization, History and Evolution of Treatment, Prevention, Screening & Surveillance - [50]
Lu RJ, Homer A, Lee M et al.. “MRSA Necrotizing Fasciitis of the Neck and Chest in a 3-Month-Old Infant.” The Laryngoscope (2025). PMID: 40919819 ↗
L4CASE_REPORTCited in: Diagnosis and Workup - [51]
Walther A, De Marco G, Vazquez O et al.. “Synchronous Multifocal Necrotizing Fasciitis in an Infant: A Case Report.” The Pediatric infectious disease journal (2025). PMID: 40526874 ↗
L4CASE_REPORTCited in: Diagnosis and Workup - [52]
Menier L, Balandraud A, Choufani C et al.. “Travel-related sepsis with colitis and necrotizing skin and soft tissue infection after oysters consumption.” European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2025). PMID: 40304897 ↗
L4CASE_REPORTCited in: Diagnosis and Workup, History and Evolution of Treatment - [53]
Silverii GA, Dicembrini I, Monami M et al.. “Fournier's gangrene and sodium-glucose co-transporter-2 inhibitors: A meta-analysis of randomized controlled trials.” Diabetes, obesity & metabolism (2019). PMID: 31637829 ↗
L1SR_MA_RCTCited in: Severity, Surgical Scoring and Risk Stratification - [54]
Keeling PA, Domes CM. “A Systematic Review of the Laboratory Risk Indicator for Necrotizing Fasciitis Score and Its Utility in Orthopedics for Diagnosing Necrotizing Fasciitis in Adults.” Orthopedics (2019). PMID: 30964538 ↗
L5SR_OBSCited in: Severity, Surgical Scoring and Risk Stratification - [55]
Li X, Zhang Y, Xiong F et al.. “Comparison between vacuum sealing drainage (VSD) and conventional dressing for fournier's gangrene: a single-centre retrospective study.” BMC surgery (2025). PMID: 41094492 ↗
L3COHORTCited in: Severity, Surgical Scoring and Risk Stratification, Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization - [56]
Stallwood-Hall C, Binu V, Rajendran RK et al.. “Validating the laboratory risk indicator for necrotizing fasciitis (LRINEC) score: a prospective cohort study in a resource limited setting.” ANZ journal of surgery (2024). PMID: 38197526 ↗
L2COHORTCited in: Severity, Surgical Scoring and Risk Stratification - [57]
Khamnuan P, Chuayunan N, Duangjai A et al.. “Novel clinical risk scoring model for predicting mortality in patients with necrotizing fasciitis: The MNF scoring system.” Medicine (2021). PMID: 34941083 ↗
L3RCTCited in: Severity, Surgical Scoring and Risk Stratification - [58]
Wu H, Liu S, Li C et al.. “Modified Laboratory Risk Indicator for Necrotizing Fasciitis (m-LRINEC) Score System in Diagnosing Necrotizing Fasciitis: A Nested Case-Control Study.” Infection and drug resistance (2021). PMID: 34113137 ↗
L3CASE_CONTROLCited in: Severity, Surgical Scoring and Risk Stratification - [59]
Gambichler T, Rasched NA, Susok L et al.. “Model for End-Stage Liver Disease Is a Novel Potential Predictor of 30-Day Mortality in Patients With Necrotizing Fasciitis.” International journal of dermatology (2025). PMID: 41024368 ↗
L3OTHERCited in: Severity, Surgical Scoring and Risk Stratification - [60]
van Kempen EB, Tulling AJ, von Asmuth EGJ et al.. “Risk Factors for Severe Pediatric Invasive Group A Streptococcal Disease.” JAMA network open (2025). PMID: 40828532 ↗
L3OTHERCited in: Severity, Surgical Scoring and Risk Stratification - [61]
Long Q, Yue C, He B et al.. “Multiple skip incision skin-sparing debridement for perianal necrotizing fasciitis: a retrospective study.” World journal of emergency surgery : WJES (2025). PMID: 40770721 ↗
L3COHORTCited in: Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Prognosis and Natural History, Special Populations & Pregnancy, Prevention, Screening & Surveillance - [62]
Roje Z, Roje Z, Matić D et al.. “Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs.” World journal of emergency surgery : WJES (2011). PMID: 22196774 ↗
L5CASE_REPORTCited in: Acute Management and Resuscitation - [63]
Mladenov A, Diehl K, Müller O et al.. “Outcome of necrotizing fasciitis and Fournier's gangrene with and without hyperbaric oxygen therapy: a retrospective analysis over 10 years.” World journal of emergency surgery : WJES (2022). PMID: 35932075 ↗
L3OTHERCited in: Acute Management and Resuscitation, Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Prognosis and Natural History - [64]
Patel A, Batura D. “Hyperbaric oxygen therapy and Fournier's gangrene: a systematic review and meta-analysis.” Medical gas research (2026). PMID: 41575004 ↗
L3SR_OBSCited in: Acute Management and Resuscitation - [65]
Nawijn F, Smeeing DPJ, Houwert RM et al.. “Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis.” World journal of emergency surgery : WJES (2020). PMID: 31921330 ↗
L2SR_OBSCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prognosis and Natural History - [66]
Wang Q, Yang X, Wei Z et al.. “The Effect of NPWT on Odontogenic Cervical Necrotizing Fasciitis.” The Journal of craniofacial surgery (2024). PMID: 39283081 ↗
L1RCTCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization - [67]
Chernov D, Frappa N, Alben MG et al.. “Hip disarticulation and external hemipelvectomy for infectious indications: a systematic review.” European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2026). PMID: 42295459 ↗
L4SR_OBSCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Complications and Their Management, Prognosis and Natural History - [68]
Ferrara M, Romano V, Longo L et al.. “Life-threatening complications in ophthalmic surgery: a systematic review.” Eye (London, England) (2024). PMID: 39580602 ↗
L5SR_OBSCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice - [69]
Seternes A, Rekstad LC, Mo S et al.. “Open Abdomen Treated with Negative Pressure Wound Therapy: Indications, Management and Survival.” World journal of surgery (2017). PMID: 27541031 ↗
L3OTHERCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Complications and Their Management, Prognosis and Natural History, Special Populations & Pregnancy - [70]
Chai Z, Chen D, Fan Y et al.. “Efficacy analysis of early incision and drainage on necrotizing fasciitis, a retrospective study.” BMC infectious diseases (2026). PMID: 41965554 ↗
L3COHORTCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Operative Approach, Technique Selection and Perioperative Optimization, Prognosis and Natural History, Special Populations & Pregnancy - [71]
Chen SJ, Ji N, Chen YX et al.. “Effectiveness of negative pressure wound therapy in Ludwig's angina: a retrospective study of 18 cases.” BMC surgery (2025). PMID: 40399898 ↗
L3COHORTCited in: Operative Decision-Making: Indications, Timing and the Operative-vs-Nonoperative Choice, Prevention, Screening & Surveillance - [72]
McKinney JA, Vilchez G, Jowers A et al.. “Water birth: a systematic review and meta-analysis of maternal and neonatal outcomes.” American journal of obstetrics and gynecology (2024). PMID: 38462266 ↗
L2SR_OBSCited in: Operative Approach, Technique Selection and Perioperative Optimization - [73]
Zhang R, Zhang Y, Hou L et al.. “Vacuum-assisted closure versus conventional dressing in necrotizing fasciitis: a systematic review and meta-analysis.” Journal of orthopaedic surgery and research (2023). PMID: 36737764 ↗
L1SR_OBSCited in: Operative Approach, Technique Selection and Perioperative Optimization - [74]
Suijker J, Zheng KJ, Pijpe A et al.. “The Skin-Sparing Debridement Technique in Necrotizing Soft-Tissue Infections: A Systematic Review.” The Journal of surgical research (2021). PMID: 33845413 ↗
L2SR_OBSCited in: Operative Approach, Technique Selection and Perioperative Optimization - [75]
Passemard L, Hida S, Barrat A et al.. “Eyelid and periorbital necrotizing fasciitis, a severe preseptal infection, a systemic review of the literature and anatomical illustrations.” Journal of stomatology, oral and maxillofacial surgery (2023). PMID: 37178871 ↗
L4SR_OBSCited in: Operative Approach, Technique Selection and Perioperative Optimization - [76]
Paynter JA, Qin KR, Situ D et al.. “Fournier gangrene with concurrent multifocal necrotizing fasciitis: a systematic review and case report.” Annals of coloproctology (2022). PMID: 35615761 ↗
L4SR_OBSCited in: Operative Approach, Technique Selection and Perioperative Optimization - [77]
Joseph JF, Bischoff K. “Bedside guillotine foot and ankle amputation in the emergency department due to necrotizing fasciitis.” The American journal of emergency medicine (2025). PMID: 41076347 ↗
L4CASE_REPORTCited in: Operative Approach, Technique Selection and Perioperative Optimization, History and Evolution of Treatment - [78]
Welschmeyer A, Karasik D, Quereshy H et al.. “Complex Salvage Lower Lip Reconstruction Using Gracilis Free Flap.” Facial plastic surgery & aesthetic medicine (2026). PMID: 40127990 ↗
L4CASE_REPORTCited in: Operative Approach, Technique Selection and Perioperative Optimization, History and Evolution of Treatment - [79]
Pan Z, Guo X, Huang P et al.. “Early diagnosis and application of hemopurification combined with antibiotic therapy and surgical debridement for successful treatment of a child with Vibrio vulnificus necrotizing fasciitis and septic shock: a case report.” BMC infectious diseases (2025). PMID: 40016642 ↗
L4CASE_REPORTCited in: Operative Approach, Technique Selection and Perioperative Optimization - [80]
Taviloglu K, Yanar H. “Necrotizing fasciitis: strategies for diagnosis and management.” World journal of emergency surgery : WJES (2007). PMID: 17683625 ↗
L5OTHERCited in: Complications and Their Management, Prognosis and Natural History - [81]
Wimmer L, Fankhauser CD, Mattei A et al.. “The Forgotten Suffering of Patients who Survived Fournier's Gangrene: A Systematic Review of Long-term Outcomes and Quality of Life Impairment.” European urology focus (2026). PMID: 41982033 ↗
L2SR_OBSCited in: Complications and Their Management - [82]
O'Sullivan JL, Duchow AJ. “Necrotizing Fasciitis in the Kimberley: A Five-Year Retrospective Study From a Remote Australian Health Service.” Cureus (2026). PMID: 41536629 ↗
L2COHORTCited in: Complications and Their Management - [83]
Kim DG, Lee KA. “The Usefulness of DEPAP Flaps for Reconstructing Perineal Defects Caused by Fournier's Gangrene: A Case Report.” Journal of clinical medicine (2025). PMID: 41464632 ↗
L4CASE_REPORTCited in: Complications and Their Management, Prevention, Screening & Surveillance - [84]
Karamitros G, Grant MP, Henry S et al.. “Managing Necrotizing Soft Tissue Infections of the Lower Limb: Microsurgical Reconstruction and Hospital Resource Demands-A Case Series from a Tertiary Referral Center.” Journal of clinical medicine (2025). PMID: 40364028 ↗
L2CASE_REPORTCited in: Complications and Their Management - [85]
Dunbar D, Jain S, Berle L et al.. “Diagnosing necrotizing fasciitis: is there a difference between type I and type II with respect to computer tomography scan features?” Infectious diseases (London, England) (2026). PMID: 42434860 ↗
L2OTHERCited in: Complications and Their Management - [86]
van Stigt SF, de Vries J, Bijker JB et al.. “Review of 58 patients with necrotizing fasciitis in the Netherlands.” World journal of emergency surgery : WJES (2016). PMID: 27239222 ↗
L2REVIEW_NARRATIVECited in: History and Evolution of Treatment, Prognosis and Natural History - [87]
Patiño JF, Castro D, Valencia A et al.. “Necrotizing soft tissue lesions after a volcanic cataclysm.” World journal of surgery (1991). PMID: 2031361 ↗
L4OTHERCited in: History and Evolution of Treatment - [88]
Stamenkovic I, Lew PD. “Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy.” The New England journal of medicine (1984). PMID: 6727947 ↗
L4OTHERCited in: History and Evolution of Treatment - [89]
Viste A, Vindenes H, Gjerde S. “Herniation of the stomach and necrotizing chest wall infection following laparoscopic Nissen fundoplication.” Surgical endoscopy (1997). PMID: 9381343 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [90]
Ji X, Li X, Lu Z. “Diagnostic strategies in necrotizing soft tissue infections: from clinical scores to multi-omics and machine learning.” Burns & trauma (2026). PMID: 42344314 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment - [91]
Chen L, Li J, Gao M et al.. “Transesophageal echocardiography-guided anesthetic management of a patient with dilated cardiomyopathy, severe heart failure, and septic shock: a case report.” Frontiers in medicine (2026). PMID: 42445149 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [92]
Yuan L, Sun Y, Yan J. “Case Report: A case of Fournier's gangrene of the scrotum.” Frontiers in medicine (2026). PMID: 42027829 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [93]
Zhong D, He J, Jin J et al.. “Case Report: Fatal Streptococcus pyogenes infection secondary to closed femoral fracture.” Frontiers in medicine (2026). PMID: 41859151 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [94]
Li X, Gu J, Zhang W et al.. “Fulminant necrotizing fasciitis secondary to Aeromonas dhakensis infection: a case report.” Frontiers in medicine (2025). PMID: 41267879 ↗
L4CASE_REPORTCited in: History and Evolution of Treatment - [95]
Gang J, Kim B. “The Usefulness and Limitations of Radiologic Findings for Diagnosis of Infectious Diseases: A Call for Antimicrobial Stewardship.” Infection & chemotherapy (2025). PMID: 41486435 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment - [96]
Jabbour G, El-Menyar A, Peralta R et al.. “Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital.” World journal of emergency surgery : WJES (2016). PMID: 27508002 ↗
L2OTHERCited in: Prognosis and Natural History - [97]
Dong J, Li Q, Shao X et al.. “Association between the direct bilirubin to lymphocyte ratio and mortality in patients with necrotizing fasciitis: a retrospective cohort study.” Frontiers in medicine (2026). PMID: 42305957 ↗
L2COHORTCited in: Prognosis and Natural History - [98]
Fürer AMC, Papanikolaou A, Constantinescu M et al.. “Necrotizing Fasciitis in Switzerland: Risk Factors and Clinical Outcomes Based on a 12-Year Retrospective Study.” Journal of clinical medicine (2026). PMID: 42194654 ↗
L2COHORTCited in: Prognosis and Natural History - [99]
Khan S, Ahmad R, Munir A et al.. “Trends in Necrotizing Fasciitis-Associated Mortality in the United States 2003-2020: A CDC WONDER Database Population-Based Study.” World journal of surgery (2025). PMID: 40107846 ↗
L2OTHERCited in: Prognosis and Natural History, Special Populations & Pregnancy - [100]
Bingoel AS, Dastagir K, Schmitt N et al.. “Association between procalcitonin and mortality in patients with necrotizing fasciitis: A single-center retrospective study.” JPRAS open (2026). PMID: 41948778 ↗
L2COHORTCited in: Prognosis and Natural History - [101]
Karahan M, Hacıalioğlu C, Kaya S et al.. “Comparison of diverting colostomy and fecal management catheter in fournier gangrene: a retrospective cohort study.” Frontiers in surgery (2026). PMID: 41929388 ↗
L2COHORTCited in: Prognosis and Natural History - [102]
Lee JY, Jung H, Kwon H et al.. “Extended negative pressure wound therapy-assisted dermatotraction for the closure of large open fasciotomy wounds in necrotizing fasciitis patients.” World journal of emergency surgery : WJES (2014). PMID: 24731449 ↗
L4OTHERCited in: Prevention, Screening & Surveillance - [103]
Thean LJ, Jenney A, Engelman D et al.. “Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.” PLoS neglected tropical diseases (2020). PMID: 33296378 ↗
L2COHORTCited in: Prevention, Screening & Surveillance - [104]
Jindai K, Farley T, Awori Q et al.. “Systematic review: Safety of surgical male circumcision in context of HIV prevention public health programmes.” Gates open research (2023). PMID: 37089877 ↗
L2SR_OBSCited in: Prevention, Screening & Surveillance - [105]
Yeh YS, Chen PJ, Huang SC et al.. “Global epidemiology and mortality trends of necrotizing fasciitis: a systematic review and meta-analysis with a focus on monomicrobial Gram-negative infections.” International journal of surgery (London, England) (2026). PMID: 41586618 ↗
L2SR_OBSCited in: Prevention, Screening & Surveillance - [106]
Shang C, Zhang Y, Zhong S et al.. “Case Report: Post-traumatic Aeromonas infection causing severe lower limb soft tissue infection-a report of two surviving cases.” Frontiers in medicine (2026). PMID: 42040605 ↗
L4CASE_REPORTCited in: Prevention, Screening & Surveillance - [107]
Stefan M, Brajerova M, Prasad S et al.. “Recurrence following invasive GAS infections in adults: Triumph of virulence or failure of immunity?” Virulence (2025). PMID: 41017571 ↗
L4CASE_REPORTCited in: Prevention, Screening & Surveillance